'''Diprophylline''' ([[International nonproprietary name|INN]])<ref name="INN">{{cite web | title = International Non-Proprietary Names. Recommended International Non-Proprietary Names (Rec. I.N.N.): List 1 | url = http://www.who.int/medicines/publications/druginformation/innlists/RL01.pdf | publisher = World Health Organization | page = 188 | date = 1955}}</ref> or '''dyphylline''' ([[United States Adopted Name|USAN]]) (trade names '''Dilor''', '''Lufyllin'''), is a [[xanthine]] [[Chemical derivative|derivative]] with [[bronchodilator]] and [[vasodilator]] effects. It is used in the treatment of [[Respiratory disease|respiratory disorder]]s like [[asthma]], [[Cardiac asthma|cardiac dyspnea]], and [[bronchitis]]. It acts as an [[adenosine receptor]] [[Receptor antagonist|antagonist]] and [[phosphodiesterase inhibitor]].<ref>{{cite journal | last1 = Schwabe | first1 = U | last2 = Ukena | first2 = D | last3 = Lohse | first3 = MJ | title = Xanthine Derivatives as Antagonists at A<sub>1</sub> and A<sub>2</sub> Adenosine Receptors | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | date = September 1985 | volume = 330 | issue = 3 | pages = 212–21 | doi = 10.1007/bf00572436 | pmid = 2997628}}</ref><ref>{{cite journal | last1 = Iancu | first1 = L | last2 = Shneur | first2 = A | last3 = Cohen | first3 = H | title = Trials with Xanthine Derivatives in Systemic Treatment of Psoriasis | journal = Dermatologica | date = 1979 | volume = 159 | issue = 1 | pages = 55–61 | doi = 10.1159/000250562 | pmid = 225216}}</ref>
